The fasting C‐peptide of T1D patients showed a significant increase (< 0.02 ng/mL vs. 0.31 ng/mL) after transplantation, and the daily insulin requirement reduced to half of that before transplantation, reaching a stable therapeutic effect within a few months. Here, INS is linked to type 1 diabetes mellitus.